Roche loses appeal to block market entry of rival cancer drug
07-07-2020
Biogen takes Creative Biolabs to court over antibody
19-03-2020
Testing / Shutterstock.com
Swiss company Roche has partnered with Belgium-based biopharmaceutical company UCB to develop an antibody treatment for people living with Alzheimer’s disease.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Roche, UCB, Alzheimer's disease, antibody treatment, collaboration, R&D
